首页> 外国专利> HYBRID PROTEIN BASED ON L-ASPARAGINASE Wolinella succinogenes, STRAIN Escherichia coli - PRODUCER OF HYBRID PROTEIN (VERSIONS) AND METHOD OF PRODUCING OF HYBRID PROTEIN WITH ANTICANCER ACTIVITY

HYBRID PROTEIN BASED ON L-ASPARAGINASE Wolinella succinogenes, STRAIN Escherichia coli - PRODUCER OF HYBRID PROTEIN (VERSIONS) AND METHOD OF PRODUCING OF HYBRID PROTEIN WITH ANTICANCER ACTIVITY

机译:基于L-天冬酰胺酶Wolinella succinogenes的混合蛋白,应变大肠杆菌-混合蛋白的生产商(版本)和具有抗癌活性的混合蛋白的生产方法

摘要

FIELD: biotechnologies.;SUBSTANCE: invention describes the hybrid protein based on mutant recombinant L-asparaginase of bacteria Wolinella succinogenes with lowered glutaminase activity and increased resistance to effect of trypsin linked with N-end amino-acid sequence heparin-binding peptide. The invention relates also to strains-producers and to the method of producing of this hybrid protein.;EFFECT: invention allows to expand the range of hybrid proteins based on asparaginase with anticancer activity.;4 cl, 2 dwg, 2 tbl, 27 ex
机译:发明领域:本发明描述了基于细菌Wolinella succinogenes的突变重组L-天冬酰胺酶的杂合蛋白,其具有降低的谷氨酰胺酶活性和对与N端氨基酸序列肝素结合肽相连的胰蛋白酶作用的抗性增强。本发明还涉及菌株生产者和该杂合蛋白的生产方法。效果:本发明允许基于具有抗癌活性的天冬酰胺酶扩展杂合蛋白的范围。4 cl,2 dwg,2 tbl,27 ex

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号